Tofacitinib Citrate Impurity 291 (N-Nitroso Tofacitinib Citrate Impurity 2)
- CAS3100114-23-3
- CatalogueRS-T095236
- FormulaC13H18N6O
- MW274.33
On this page
Custom synthesis — structure on request
Product identification
| Product name | Tofacitinib Citrate Impurity 291 (N-Nitroso Tofacitinib Citrate Impurity 2) |
|---|---|
| Catalogue No. | RS-T095236 |
| CAS No. | 3100114-23-3 |
| Molecular formula | C13H18N6O |
| Molecular weight | 274.33 |
| Exact mass | 274.1542 (monoisotopic) |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | Reference Standards |
| Drug substance | Tofacitinib Citrate |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-T095236 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Tofacitinib Citrate
- Standards by type (all categories)
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-T095236
- Request a quotation for RS-T095236
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Tofacitinib Citrate
All 80 further standards are on this page — 20 shown at first, then 20 more per click on Load more.
Tofacitinib Citrate
IN STOCKRS-I013035(-)-O,O'-di-p-Toluoyl-L-tartaric Acid
IN STOCKRS-Z412Q11(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine
IN STOCKRS-Z412QXI(3S,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine
CUSTOM SYNTHESISRS-Z412MT62,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine
CUSTOM SYNTHESISRS-P0061503-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol
BACK ORDERRS-Z001PNA3-Hydroxypropionitrile
IN STOCKRS-C0070064,6-dichloro-7H-pyrrolo[2,3-d]pyrimidine
IN STOCKRS-C0022187H-pyrrolo[2,3-d]pyrimidine-2,4-diol
IN STOCKRS-P030017N-Hydroxysulfosuccinimide Sodium Salt
IN STOCKRS-U054022TSTU
CUSTOM SYNTHESISRS-U016061Tofacitinib Citrate Impurity 2 Dihydrochloride
IN STOCKRS-Z401CUJTofacitinib Citrate Impurity 6
IN STOCKRS-T095063Tofacitinib Citrate Impurity 10
CUSTOM SYNTHESISRS-T095035Tofacitinib Citrate Impurity 22
BACK ORDERRS-T095016Tofacitinib Citrate Impurity 26 (Mixture of Enantiomers)
IN STOCKRS-Z412PHQTofacitinib Citrate Impurity 36
IN STOCKRS-T095049Tofacitinib Citrate Impurity 38 Monomer
IN STOCKRS-I009055Tofacitinib Citrate Impurity 41
IN STOCKRS-T095033Tofacitinib Citrate Impurity 49
BACK ORDERRS-T095018Tofacitinib Citrate Impurity 53
IN STOCKRS-T041001Tofacitinib Citrate Impurity 60
CUSTOM SYNTHESISRS-T095008Tofacitinib Citrate Impurity 77 Hydrochloride
CUSTOM SYNTHESISRS-T095067Tofacitinib Citrate Impurity 84
BACK ORDERRS-T095034Tofacitinib Citrate Impurity 85
IN STOCKRS-T095234Tofacitinib Citrate Impurity 101
CUSTOM SYNTHESISRS-T095025Tofacitinib Citrate Impurity 102
IN STOCKRS-T095027Tofacitinib Citrate Impurity 118
BACK ORDERRS-T095041Tofacitinib Citrate Impurity 122
IN STOCKRS-T095012Tofacitinib Citrate Impurity 122
IN STOCKRS-T095235Tofacitinib Citrate Impurity 132
IN STOCKRS-T095011Tofacitinib Citrate Impurity 151
CUSTOM SYNTHESISRS-U004039Tofacitinib Citrate Impurity 153
IN STOCKRS-T095020Tofacitinib Citrate Impurity 155
IN STOCKRS-T095045Tofacitinib Citrate Impurity 168
IN STOCKRS-T095048Tofacitinib Citrate Impurity 170
CUSTOM SYNTHESISRS-T095047Tofacitinib Citrate Impurity 175
BACK ORDERRS-T095015Tofacitinib Citrate Impurity 189
IN STOCKRS-T095022Tofacitinib Citrate Impurity 189 Acetate
IN STOCKRS-T095065Tofacitinib Citrate Impurity 192 Monomer
CUSTOM SYNTHESISRS-T095019Tofacitinib Citrate Impurity 195
BACK ORDERRS-T095037Tofacitinib Citrate Impurity 201
IN STOCKRS-T095066Tofacitinib Citrate Impurity 204
CUSTOM SYNTHESISRS-T095013Tofacitinib Citrate Impurity 205
CUSTOM SYNTHESISRS-T095052Tofacitinib Citrate Impurity 208
IN STOCKRS-T095046Tofacitinib Citrate Impurity 214
IN STOCKRS-T095014Tofacitinib Citrate Impurity 219
IN STOCKRS-T095054Tofacitinib Citrate Impurity 220
IN STOCKRS-T095038Tofacitinib Citrate Impurity 221
IN STOCKRS-T095017Tofacitinib Citrate Impurity 222
IN STOCKRS-Z412TJ8Tofacitinib Citrate Impurity 225
IN STOCKRS-T095005Tofacitinib Citrate Impurity 230
BACK ORDERRS-T095032Tofacitinib Citrate Impurity 232
IN STOCKRS-T095055Tofacitinib Citrate Impurity 243
IN STOCKRS-T095056Tofacitinib Citrate Impurity 245
IN STOCKRS-T095057Tofacitinib Citrate Impurity 246
IN STOCKRS-T095006Tofacitinib Citrate Impurity 253
IN STOCKRS-T095031Tofacitinib Citrate Impurity 259
IN STOCKRS-T095058Tofacitinib Citrate Impurity 263
IN STOCKRS-T095004Tofacitinib Citrate Impurity 264
IN STOCKRS-T095039Tofacitinib Citrate Impurity 265
CUSTOM SYNTHESISRS-T095040Tofacitinib Citrate Impurity 266
IN STOCKRS-Z401ITJTofacitinib Citrate Impurity 268
IN STOCKRS-T095059Tofacitinib Citrate Impurity 282
IN STOCKRS-T095030Tofacitinib Citrate Impurity 283
IN STOCKRS-T095026Tofacitinib Citrate Impurity 284
IN STOCKRS-T095060Tofacitinib Citrate Impurity 286
IN STOCKRS-I002136Tofacitinib Citrate Impurity 288
CUSTOM SYNTHESISRS-T095051Tofacitinib Citrate Impurity 302
CUSTOM SYNTHESISRS-Z396PGCTofacitinib Citrate Impurity 304
IN STOCKRS-T095023Tofacitinib Citrate Impurity 306
IN STOCKRS-T095050Tofacitinib Citrate Impurity 307
IN STOCKRS-T095061Tofacitinib Citrate Impurity 311
IN STOCKRS-T095029Tofacitinib Citrate Impurity 313
CUSTOM SYNTHESISRS-T095007Tofacitinib Citrate Impurity 314
IN STOCKRS-T095053Tofacitinib Citrate Impurity 315
IN STOCKRS-T095028Tofacitinib Citrate Impurity 326
BACK ORDERRS-T095062
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.


![Chemical structure of (3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine](/structures/w4/SFJWJKDDYBNESX-SCZZXKLOSA-N.webp?v=11)


![Chemical structure of 2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine](/structures/w4/DTDGVNQSPAWHTH-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of 3-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol](/structures/w4/AUJXLBOHYWTPFV-UHFFFAOYSA-N.webp?v=11)

![Chemical structure of 4,6-dichloro-7H-pyrrolo[2,3-d]pyrimidine](/structures/w4/CGTRULURZFVPIX-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of 7H-pyrrolo[2,3-d]pyrimidine-2,4-diol](/structures/w4/HASUWNAFLUMMFI-UHFFFAOYSA-N.webp?v=11)

![Chemical structure of N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine Dihydrochloride](/structures/w4/JZRCEFVKGXWGDP-SFGLUTOSSA-N.webp?v=11)

































































